Moreover, IL-22 increases intestinal barrier function and anti-microbial peptide production (64, 65), and iNKT cells trigger ILC3s to produce IL-22 in the intestine (18), indicating that secretion of IL-22 by ILC3s following their interaction with iNKT cells might be effective in preventing colitis development. Here, IL22 is linked to colitis.